EMIRODATAMAB
UNII P9I9Z3MF7Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Emirodatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P9I9Z3MF7Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2449199-61-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

P9I9Z3MF7Z

CAS Registry Number

2449199-61-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EMIRODATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156399

National Cancer Institute reference terminology for clinical and research data.

INN ID

12028

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-112

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emirodatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMIRODATAMAB

Common Names & Synonyms

ANTI-FLT3/CD3 BITE ANTIBODY AMG 427

EMIRODATAMAB [INN]

EMIRODATAMAB [USAN]

EMIRODATAMAB [WHO-DD]

EXTENDED HALF-LIFE ANTI-FLT3 X ANTI-CD3 BITE (BISPECIFIC T CELL ENGAGER) ANTIBODY CONSTRUCT

IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN FMS-LIKE TYROSINE KINASE FLT3) (HUMAN MONOCLONAL FLT3_BISPECIFIC_1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN .EPSILON.-CHAIN) (HUMAN MONOCLONAL FLT3_BISPECIFIC_1 SINGLE-CHAIN VARIABLE FRAGMENT VH2-(GGGGS)3-VL2) FUSION PROTEIN WITH PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)6 FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT)

Technical Codes

AMG 427

AMG-427

External Clinical & Regulatory Resources

Previous UNIIP9I08W532U

Next UNIIP9IDH7V81L